Open Access Week - 22 to 28 October

The International Open Access Week runs from 22 to 28 October and promotes Open Access.

Within the framework of the Office of Research and Innovation, in collaboration with the Libraries, a program of workshops was prepared for the 4 centers of the UCP:

EBSCO Discovery Service (EDS): A Path to Research and Knowledge

- 22/10, 10h-11h20, Biblioteca Eduardo Coelho, Lisboa

Live broadcast to all centers: Braga- room B (Edifício B, Campus Camões), Porto- room of Executives (Campus Foz) and Viseu- room of Videoconference (1st floor)

Open Access Journals vs. Predatory Journals

- 22/10, 14h-16h, room –EC102, Campus Foz, Porto

- 23/10, 10h30-12h30, room 255, Ed. Antigo, Lisboa

- 25/10, 11h-13h, Lab. de Anatomia (piso 1) Ed. Medicina Dentária, Viseu

- 26/10 Computers room, Fac. Filosofia e Ciências Sociais, Braga

Green & Gold Open Access

- 22/10, 16h-18h, room –EC102, Campus Foz, Porto

- 23/10, 14h-16h, room 255, Ed. Antigo, Lisboa

- 25/10, 14h-16h, Lab. de Anatomia (piso 1) Ed. Medicina Dentária, Viseu

- 26/10 Computers room, Fac. Filosofia e Ciências Sociais, Braga

Limited enrollment: gii@ucp.pt.

Transform4Europe International
Choose optional courses at European universities!
Universidade Católica Portuguesa's students can sign up for optional courses at Transform4Europe 10 partner universities. Learn how to apply.
Católica Research
Católica alumni awarded Fulbright scholarships for 2026/2027
Three alumni of Universidade Católica Portuguesa have been awarded Fulbright scholarships for the 2026/2027 academic year, a distinction that will enable them to carry out research projects and pursue further studies in the United States of America. Find out more here.
Católica Biomedical Research Center Research
CBR Researcher Awarded ERC Proof of Concept Grant to Develop a New Generation of Influenza Antiviral Drugs
Maria João Amorim, a researcher at CBR and associate professor at Católica Medical School, has been awarded a European Research Council (ERC) Proof of Concept (PoC) Grant to develop an innovative approach to combating influenza A virus. Read more.